519 672 2121
Close mobile menu

Invokana (canagliflozin) is a prescription medication indicated to lower blood sugar in adults with type 2 diabetes. Invokana is also available in combination with metformin, under the brand name Invokamet.

In November 2021, a Canada-wide Settlement was reached to resolve litigation against Janssen Inc., Janssen Pharmaceuticals, Inc., Janssen Ortho LLC, Johnson & Johnson, and Johnson & Johnson Inc. The Settlement was approved by the Superior Court of Quebec, the Ontario Superior Court of Justice, and the Saskatchewan Court of King’s Bench.

The claim period has now passed (August 14, 2023) and no further claims are being accepted. For this reason, we are no longer accepting new clients in these matters.

You can get more information by visiting the settlement website invokanacanadasettlement.com or by contacting the claims administrator at 1.877.400.1211.

Developments

A Canada-wide settlement has been reached in class action litigation relating to the prescription drugs Invokana, Invokamet, and Invokamet XR. The Settlement Agreement can be consulted here: [english] [french*] *please note that this version is not an official translation

The Settlement was approved by the Superior Court of Quebec on November 23, 2022, by the Ontario Superior Court of Justice on September 30, 2022, and by the Saskatchewan Court of King’s Bench on February 13, 2023.

For more information, please consult the detailed notice to members [English], [French].

The settlement is now closed to new claims. The Claims Deadline for the settlement passed on November 14, 2023.

FAQs

I still have a question. Who should I contact?

For more information about the settlement, visit the Claims Administrator dedicated page invokanacanadasettlement.com. You can also contact the Claims Administrator by phone at 1.877.400.1211 or by email at [email protected].

Documents

Quebec proceedings

A Canada-wide settlement has been reached in class action litigation relating to the prescription drugs Invokana, Invokamet, and Invokamet XR. The Settlement Agreement can be consulted here: [english] [french*] *please note that this version is not an official translation

The Settlement was approved by the Superior Court of Quebec on November 23, 2022, by the Ontario Superior Court of Justice on September 30, 2022, and by the Saskatchewan Court of King’s Bench on February 13, 2023.

For more information, please consult the detailed notice to members [English], [French].

The settlement is now closed to new claims. The Claims Deadline for the settlement passed on November 14, 2023.

I still have a question. Who should I contact?

For more information about the settlement, visit the Claims Administrator dedicated page invokanacanadasettlement.com. You can also contact the Claims Administrator by phone at 1.877.400.1211 or by email at [email protected].

Quebec proceedings